Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
NCT06024356
·
clinicaltrials.gov ↗
UNKNOWN
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Neoplasms
Interventions
DRUG:
Thymalfasin
Sponsor
Beijing Friendship Hospital